Your browser doesn't support javascript.
loading
Professionals' treatment goals for long-term benzodiazepine and Z-drugs management: a qualitative study.
Van Ngoc, Pauline; Ceuterick, Melissa; Belche, Jean-Luc; Scholtes, Beatrice.
Afiliación
  • Van Ngoc P; Research Unit of Primary Care and Health, Department of General Medicine, University of Liège, Liège, Belgium pauline.vanngoc@uliege.be.
  • Ceuterick M; Hedera, Department of Sociology, Ghent University, Ghent, Belgium.
  • Belche JL; Research Unit of Primary Care and Health, Department of General Medicine, University of Liège, Liège, Belgium.
  • Scholtes B; Research Unit of Primary Care and Health, Department of General Medicine, University of Liège, Liège, Belgium.
BJGP Open ; 2024 Feb 06.
Article en En | MEDLINE | ID: mdl-37726172
ABSTRACT

BACKGROUND:

Benzodiazepines and Z-drugs (BZD/Z) are frequently prescribed for longer than recommended. Through their interactions with patients taking BZD/Z, primary care and mental health professionals play a key role in the management of this medication.

AIM:

To explore how primary care and mental health care professionals set treatment goals with users of long-term BZD/Z. DESIGN &

SETTING:

A qualitative study using semi-structured interviews with professionals from mental health, addiction care, and primary care practices in Belgium.

METHOD:

Semi-structured interviews were conducted, online and in person, with 24 professionals working in mental health and primary care. Inductive thematic content analysis was performed.

RESULTS:

Seven themes were identified from the analysis. Professionals tended not to use the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) standard to diagnose a BZD/Z substance use disorder. They described criteria based on their experience. They identified diverse types of patients that influence their choice of treatment goals. Professionals appeared to position themselves according to their own treatment goals for their patients, either by promoting the goal of abstinence or harm reduction. Some of them reported feeling trapped into continuing to prescribe and considered BZD/Z withdrawal to be difficult. Some were afraid to engage in a conversation that might break the bond of trust with the patient. Few professionals mentioned patient participation in the treatment goal setting. They asked for targeted withdrawal recommendations, perceiving the current recommendations to be too broad.

CONCLUSION:

Whether primary care or mental health care professionals are more in favour of a total abstinence or a harm reduction approach to BZD/Z, professionals should be guided towards greater patient participation in setting and evaluating goals with patients taking BZD/Z.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: BJGP Open Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: BJGP Open Año: 2024 Tipo del documento: Article País de afiliación: Bélgica